Azithromycin Safety During Pregnancy

Azithromycin is an antibiotic that belongs to the macrolide class, which also includes clarithromycin, erythromycin, spiramycin and telithromycin. It is commonly prescribed to treat a wide range of infections, including sexually transmitted infections, respiratory infections, and skin infections.

There is some debate about the safety of azithromycin during pregnancy, and whether it may increase the risk of miscarriage or birth defects. While some studies suggest that azithromycin is relatively safe and does not increase the risk of major malformations, others indicate a possible link to miscarriage and certain types of birth defects.

Overall, azithromycin is categorised as pregnancy class B, indicating that it is likely safe for use during pregnancy. However, it is recommended only when clearly needed and when the benefits outweigh the risks.

Azithromycin is generally considered safe to take during pregnancy

According to the US FDA pregnancy risk categories, azithromycin is classified as category B, which means there is no evidence of risk to the foetus in animal studies. This categorisation indicates that azithromycin is relatively safer than other antibiotics like clarithromycin, which is categorised as category C, meaning there is a potential risk to the foetus.

Several studies have been conducted to evaluate the safety of azithromycin during pregnancy, and the results are reassuring. Animal studies have not shown any evidence of fetotoxicity or teratogenicity, and human studies have not identified any drug-related risks for major birth defects, miscarriage, or adverse maternal/fetal outcomes. One study compared pregnancy outcomes in women who took azithromycin with those who took non-teratogenic antibiotics or no antibiotics at all, and found no significant differences in the rates of major malformations.

However, it is important to note that azithromycin should only be used during pregnancy when clearly needed and when the benefits outweigh the risks. While azithromycin is generally considered safe, there are some conflicting findings in the research. Some studies have suggested a possible association between azithromycin use and an increased risk of miscarriage, major malformations, cardiovascular malformations, and digestive system malformations.

Therefore, while azithromycin is generally considered safe during pregnancy, it is important for pregnant women to consult with their healthcare providers and carefully consider the benefits and risks before taking any medication, including azithromycin.

It is used to treat infections in pregnant women

Azithromycin is a common antibiotic used to treat infections in pregnant women. It is used to treat sexually transmitted diseases, toxoplasmosis, malaria, preterm pre-labour rupture of membranes, and as a prophylaxis for cesarean delivery.

Azithromycin is considered safe for use during pregnancy, with no evidence of risk to the fetus in animal studies. However, it should only be used when clearly needed and when the benefits outweigh the risks.

Azithromycin has been found to be well-tolerated, with a good safety profile. It has a low risk of adverse effects, with only 1% of users discontinuing the drug due to adverse effects, compared to 20% for erythromycin. The most common adverse effects are nausea and vomiting, which occur with high doses and prolonged treatments.

There is limited data on the effects of azithromycin during pregnancy, with some studies reporting an increased risk of spontaneous miscarriage, major congenital malformations, cardiovascular malformations, digestive system malformations, preterm birth, and low birth weight. However, other studies have found no significant association between azithromycin use and these outcomes.

Overall, azithromycin appears to be a safe and effective option for treating infections in pregnant women, but more high-quality data is needed to fully understand the risks and benefits.

Animal studies have not shown evidence of fetotoxicity or teratogenicity

Animal studies have shown that azithromycin is safe for use during pregnancy. In animal reproductive studies, azithromycin did not cause impaired fertility or harm to the foetus.

In one study, azithromycin was administered to rats and mice at oral doses up to 200 mg/kg/day during organogenesis. This dose is about 4 (rats) and 2 (mice) times an adult human dose of 500 mg. The drug did not cause foetal malformations in these animals.

In another study, rabbits were given oral doses of 10, 20, and 40 mg/kg/day during organogenesis. The highest dose is estimated to be 2 times an adult human daily dose of 500 mg. No evidence of foetal harm was seen at these doses.

It is important to note that azithromycin crosses the placenta, as shown in animal studies. However, the available data from animal and human studies do not indicate an increased risk of major birth defects, miscarriage, or adverse maternal/foetal outcomes associated with the use of this drug during pregnancy.

Overall, azithromycin is considered safe for use during pregnancy, and the benefits of treating infections are thought to outweigh any potential risks to the mother and foetus.

There is no evidence of an increased risk of miscarriage or adverse maternal/fetal outcomes

Azithromycin is a macrolide antibiotic commonly prescribed during pregnancy. It is used to treat sexually transmitted diseases, toxoplasmosis, malaria, and some obstetric conditions.

According to the US Food and Drug Administration (FDA), azithromycin is categorised as "Pregnancy Category B", meaning that there is no evidence of risk in humans and no evidence of fetotoxicity or teratogenicity in animal studies.

Observational studies and clinical trials have found no evidence of an increased risk of miscarriage or adverse maternal/fetal outcomes associated with azithromycin use during pregnancy.

One large observational study of 123 pregnant women who took azithromycin found no statistically significant differences in the rates of major malformations compared to two control groups. Another study of 161 pregnant women treated with azithromycin and 953 receiving other antibiotics or non-teratogens found no significant difference in the rate of congenital cardiovascular malformations between the groups.

While azithromycin is considered relatively safe during pregnancy, it should only be used when clinically indicated and when the benefits of treatment are expected to outweigh the potential risks.

It is also used to treat infections in women who are breastfeeding

Azithromycin is generally considered safe to take while breastfeeding. However, it is important to consult a doctor or healthcare professional before taking the drug, as there are some potential side effects to be aware of.

Azithromycin is an antibiotic that can pass into breast milk in small amounts. While it has not been known to cause any side effects in breastfed babies, it is always recommended to monitor infants for any potential issues. Some possible side effects to be aware of include gastrointestinal problems, such as vomiting, diarrhea, and candidiasis (thrush or diaper rash). In addition, there is some unconfirmed evidence that suggests maternal use of macrolide antibiotics during the first two weeks of breastfeeding may increase the risk of infantile hypertrophic pyloric stenosis, but this relationship is not yet fully understood.

It is important to note that azithromycin should not be taken by women with existing heart conditions, as it may cause heart rhythm changes. Additionally, women with a history of allergic reactions to macrolides or ketolides should avoid taking this drug.

When deciding whether to take azithromycin while breastfeeding, it is crucial to weigh the benefits of the drug for the mother against the potential risks to the child. It is always best to consult a healthcare professional to make an informed decision and ensure the safety of both the mother and the baby.

Frequently asked questions